Journal of Oral and Maxillofacial Surgery
Volume 64, Issue 11 , Pages 1672-1679 , November 2006

Patient With Multiple Primary Carcinomas Including 4 Separate Oral Cancers: Study of p53 Mutations and Their Implications for Management

  • Masakatsu Fukuda, DDS, PhD

      Affiliations

    • Assistant Professor, Second Department of Oral and Maxillofacial Surgery, Meikai University School of Dentistry, Saitama, Japan.
    • Corresponding Author InformationAddress correspondence and reprint requests to Dr Fukuda: Second Department of Oral and Maxillofacial Surgery, Meikai University School of Dentistry, 1-1 Keyakidai, Sakado, Saitama 350-0283 Japan.
    • ,
  • Takashi Nakatsuka, MD, PhD

      Affiliations

    • Professor, Department of Plastic Surgery, Saitama Medical School, Saitama, Japan.
    • ,
  • Kaoru Kusama, DDS, PhD

      Affiliations

    • Professor, Department of Oral Pathology, Meikai University School of Dentistry, Saitama, Japan.
    • ,
  • Hideaki Sakashita, DDS, PhD

      Affiliations

    • Professor, Second Department of Oral and Maxillofacial Surgery, Meikai University School of Dentistry, Saitama, Japan.

References 

  1. Licciardello JT, Spitz MR, Hong WK. Multiple primary cancer in patients with cancer of the head and neck: Second cancer of the head and neck, esophagus, and lung. Int J Radiat Oncol Biol Phys. 1989;17:467
  2. Sakashita H, Miyata M, Miyamoto H, et al. A case of quadruple cancer, including triple cancers in the head and neck region. J Oral Maxillofac Surg. 1996;54:501
  3. Slaughter DP, Southwick HW, Smejkal W. “Field cancerization” in oral stratified squamous epithelium. Cancer. 1953;6:963
  4. Nylander K, Dabelsteen E, Hall PA. The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. J Oral Pathol Med. 2000;29:413
  5. Pindborg JJ, Reichart PA, Smith CJ, et al. Histological typing of cancer and precancer of the oral mucosa. In: World Health Organization International Histological Classification of tumors. (ed 2). Heidelberg, New York Berlin: Springer-Verlag; 1997;
  6. Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin-fixed and paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem. 1991;39:741
  7. Brüstle O, Ohgaki H, Schmitt HP, et al. Primitive neuroectodermal tumors after prophylactic central nervous system irradiation in children: Association with an activated K-ras gene. Cancer. 1992;69:2385
  8. Warren S, Gates O. Multiple primary malignant tumor: A survey of the literature and a statistical study. Am J Cancer. 1932;16:1358
  9. Moertel CG. Multiple primary malignant neoplasms: Historical perspectives. Cancer. 1977;40:1786
  10. Gluckman JL, Crissman JD. Survival rates in 548 patients with multiple neoplasms of the upper aerodigestive tract. Laryngoscope. 1983;93:71
  11. Cooper JS, Pajak TF, Rubin P, et al. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the ROTG experience. Int J Radiat Oncol Biol Phys. 1989;17:449
  12. Weinberg RA. Oncogenes, antioncogenes, and the molecular basis of multistep carcinogenesis. Cancer Res. 1989;49:3713
  13. Hollstein M, Sidransky D, Vogelstein B, et al. p53 mutations in human cancers. Science. 1991;253:49
  14. Somers KD, Merrick MA, Lopez ME, et al. Frequent p53 mutations in head and neck cancer. Cancer Res. 1992;52:5997
  15. Caamano J, Zhang SY, Rosvold EA, et al. p53 alterations in human squamous cell carcinomas and carcinoma cell lines. Am J Pathol. 1993;142:1131
  16. Tjebbes GW, Leppers vd Straat FG, Tilanus MG, et al. p53 tumor suppressor gene as a clonal marker in head and neck squamous cell carcinoma: p53 mutations in primary tumor and matched lymph node metastases. Oral Oncol. 1999;35:384
  17. Shin DM, Kim J, Ro JY, et al. Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res. 1994;54:321
  18. Obata A, Eura M, Sasaki J, et al. Clinical significance of p53 functional loss in squamous cell carcinoma of the oropharynx. Int J Cancer. 2000;89:187
  19. Langdon JD, Partridge M. Expression of the tumor suppressor gene p53 in oral cancer. Br J Oral Maxillofac Surg. 1992;30:214
  20. Kärjä VJ, Syrjänen KJ, Kurvinen A-K, et al. Expression and mutations of p53 in salivary gland tumors. J Oral Pathol Med. 1997;26:217
  21. Bromidge T, Lowe C, Prentice A, et al. p53 intronic point mutation, aberrant splicing and telomeric associations in a case of B-chronic lymphocytic leukemia. Br J Haematol. 2000;111:223
  22. Patrikidou A, Bennett J, Abou-Sleiman P, et al. A novel, de novo germline TP53 mutation in a rare presentation of the Li-Fraumeni syndrome in the maxilla. Oral Oncol. 2002;38:383
  23. Li FP, Fraumeni JF. Rhabdomyosarcoma in children: Epidemiologic study and identification of a familial cancer syndrome. J Natl Cancer Inst. 1969;43:1365
  24. Li FP, Fraumeni JF. Soft-tissue sarcomas, breast cancer, and other neoplasms (A familial syndrome?). Ann Intern Med. 1969;71:747
  25. Birch JM, Hartley AL, Blair V, et al. Cancer in the families of children with soft tissue sarcoma. Cancer. 1990;66:2239
  26. Strong LC, Stine M, Norsted TL. Cancer in survivors of childhood soft tissue sarcoma and their relatives. J Natl Cancer Inst. 1987;79:1213
  27. Li FP, Fraumeni JF. Prospective study of a family cancer syndrome. JAMA. 1982;247:2692
  28. van Oijen MG, Slootweg PJ. Oral field cancerization: Carcinogen-induced independent events or micrometastatic deposits?. Cancer Epidemiol Biomarkers Prev. 2000;9:249

PII: S0278-2391(06)00427-7

doi: 10.1016/j.joms.2006.03.035

Journal of Oral and Maxillofacial Surgery
Volume 64, Issue 11 , Pages 1672-1679 , November 2006

Article Tools

* Image Usage & Resolution